Recent updates on gonorrhoea antimicrobial resistance in Ireland

Two reports on gonorrhoea antimicrobial resistance in Ireland have recently been published. Antimicrobial resistance in Neisseria gonorrhoeae (N. gonorrhoeae) is a growing global threat and the World Health Organization (WHO) has warned that gonorrhoea may become untreatable in the future due to antimicrobial resistance, if new antimicrobial drugs do not become available.

Click link for details: Reports

New ReAct Report: When the Drugs Don’t Work – Antibiotic Resistance as a Global Development Problem

2019-02-28

Working antibiotics have given us a huge boost in quality of life over the last nine decades, but their importance and value is overlooked. Antibiotics play a crucial role in many more areas of life than most people imagine. This new report by ReAct and Dag Hammarskjöld Foundation looks at the state of global development when the drugs don’t work and a post-antibiotic era sets in. The report shows how antibiotic resistance is a global development problem by highlighting existing data and people’s experiences.

Click for Report: Report

All Island Diagnostics Conference on Disease Prevention, Infection control and AMR

6th June 2019, Belfast

Overview

The All Island Diagnostics conference is an inspiring event examining the role of both molecular and rapid diagnostics in tackling disease, infection and reducing the impact of antimicrobial resistance within our communities and hospitals. The conference and exhibition will explore how Northern Ireland and Ireland health professionals, academics and industry are driving diagnostics usage within laboratories, pharmacies and community practice.

The conference builds on the UK Diagnostics Summit held annually in London and will discuss how diagnostics are tackling cancer, diabetes, sepsis, urinary tract infections and HAI’S. This is a must attend event, targeted to those who are responsible for managing the smarter delivery of diagnostics services and determining precise diagnosis for their patients.

The event will bring together 150 NHS and HSE diagnostics leaders including service managers and diagnostic consultant medical doctors from across Northern Ireland & Ireland.

Click on link for details All Island Diagnostics Conference

Molecular methods for antimicrobial resistance (AMR) diagnostics to enhance the Global Antimicrobial Resistance Surveillance System

Antimicrobial resistance (AMR) is a serious threat to global public health. In 2015, WHO launched the Global Antimicrobial Resistance Surveillance System (GLASS) in order to standardize the collection of data on AMR for planning, prevention and intervention programmes. Reports to GLASS currently rely on detection of phenotypic resistance, however in the future, GLASS may incorporate the results of molecular testing for AMR detection by appropriate methods. Molecular diagnostic methods can be used with phenotypic testing to yield additional information. This technical note provides information to those involved at various levels of AMR surveillance in choosing the most appropriate molecular AMR test for their setting, including clinical and reference laboratories. The document also provides a review of available methods and how they could be used in national surveillance.

Click Link for Report: Report

The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2017

The data on antimicrobial resistance in zoonotic and indicator bacteria in 2017, submitted by 28 EU Member States (MSs), were jointly analysed by EFSA and ECDC. Resistance in zoonotic Salmonella and Campylobacter from humans, animals and food, and resistance in indicator Escherichia coli as well as meticillin-resistant Staphylococcus aureus in animals and food were addressed, and temporal trends assessed. ‘Microbiological’ resistance was assessed using epidemiological cut-off (ECOFF) values; for some countries, qualitative data on human isolates were interpreted in a way which corresponds closely to the ECOFF-defined ‘microbiological’ resistance.

Click on link to download the Report Report PDF

New policy brief on tackling antibiotic resistance provides policy guidance using a cultural contexts approach

Understanding how cultural factors shape the use, transmission and regulation of antibiotics can help improve the fight against antibiotic resistance (ABR), argues a new WHO policy brief launched today. ABR is a critical contemporary global health challenge. By helping to recast ABR as a social and cultural as well as a biological issue, the policy brief broadens the basis for possible policy intervention and action to reduce ABR.

Click link for report: Report

UK 20-year vision for Antimicrobial Resistance

Click to Link: UK 20-year vision for antimicrobial resistance

The vision and plan were developed across the government, its agencies and administrations in Scotland, Wales and Northern Ireland, with support from a range of stakeholders.

It is supported by the UK 5-year action plan for antimicrobial resistance 2019 to 2024. Click to Link

Both documents build on the achievements of the UK 5-year AMR strategy 2013 to 2018.

UK One Health Report: antibiotic use and antibiotic resistance in animals and humans

Click on Link: One Health Report

The second UK One-Health Report is a cross-government initiative that brings together UK data (2013-2017), on antibiotic resistance in key bacteria that are common to animals and humans, and isolated in meat at retail.

The report also includes details on amount of antibiotics sold for use in animals and antibiotics prescribed to humans.

The report aims to:
•support joint working between the animal, human, environment and food sectors
•assess the occurrence of resistance along the food chain
•add context to the surveillance data by providing information on control measures in place to reduce the risk of bacterial transmission and on policy decisions taken to tackle antibiotic resistance
•identify the current antibiotic resistance levels in four key bacteria in animals, in humans and in retail meat
•present available data from humans, animals and retail meat side by side
•provide progress updates on the ten recommendations made in the previous One Health Report